Nefopam 30mg tablets

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Nefopam hydrochloride

থেকে পাওয়া:

Rivopharm (UK) Ltd

এটিসি কোড:

N02BG06

INN (আন্তর্জাতিক নাম):

Nefopam hydrochloride

ডোজ:

30mg

ফার্মাসিউটিকাল ফর্ম:

Oral tablet

প্রশাসন রুট:

Oral

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 04070100; GTIN: 5060388650483

তথ্য লিফলেট

Lineagrafica sa
6596 Gordola
Bozza no.: 17 / Recto
Data: 06.06.17
Formato: mm 190 x 240
Nefopam Hydrochloride 30 mg RIVO UK
Colore: Nero
In this leaflet:
1. What Nefopam tablets are and what they are used for
2. Before you take Nefopam tablets
3. How to take Nefopam tablets
4. Possible side effects
5. How to store Nefopam tablets
6. Contents of the pack and other information
1. WHAT NEFOPAM TABLETS ARE
AND WHAT THEY ARE USED FOR
The full name of your medicine is Nefopam Hydrochloride
30 mg Film-coated tablets. In this leaflet the shorter name
Nefopam tablets is used.
Nefopam tablets belong to a group of medicines called
analgesics, commonly known as pain killers or pain relievers.
The active substance, nefopam hydrochloride, interrupts the
pain messages being sent to your brain, and it also acts in
your brain to stop pain messages being felt.
This means that Nefopam tablets do not stop the pain from
happening, but you will not be able to feel the pain as much.
Nefopam tablets are used to relieve of acute and chronic
pain (for example pain after an operation, dental pain, joint
or muscle pain, after an injury, or pain caused by cancer).
Nefopam tablets should not be used to treat the pain from a
heart attack.
2. WHAT YOU NEED TO KNOW
BEFORE YOU TAKE NEFOPAM TABLETS
Do not take Nefopam tablets
s
)FYOUAREACHILDUNDERYEARSOLD
s
9OUHAVEEVERHADANALLERGICREACTIONTONEFOPAM
hydrochloride or any of the ingredients resulting in a skin
rash, swelling of the face of difficulty in breathing (see
section 6. Contents of the pack and other information).
s
9OUARETAKINGMONOAMINEOXIDASEINHIBITORS-!/)S TO
treat your depression.
s
9OUHAVEORHAVEEVERHADEPILEPSYlTS 
Warnings and precautions
If the answer to any of the following is ‘yes’, you
must tell your doctor – your doctor may decide to alter
your treatment.
s
!REYOUPREGNANTORBREASTFEEDING
s
$OYOUHAVESEVEREPROBLEMSWITHYOURLIVERORKIDNEYS
s
$OYOUHAVEORHAVEYOUHADINTHEPASTDIFlCULTYPASSING
URINE
s
!REYOUTAKINGOTHERMEDICINES
Other medicines and Nefopam tablets
Please tell

পণ্য বৈশিষ্ট্য

OBJECT 1
NEFOPAM HYDROCHLORIDE 30 MG FILM-COATED
TABLETS
Summary of Product Characteristics Updated 15-Feb-2018 | Rivopharm UK
Ltd
1. Name of the medicinal product
Nefopam Hydrochloride 30 mg film-coated tablets
2. Qualitative and quantitative composition
Each tablet contains 30 mg of nefopam hydrochloride.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated tablets
White, round, biconvex, 7.1 mm diameter tablets
4. Clinical particulars
4.1 Therapeutic indications
Nefopam 30 mg tablets are indicated for the relief of acute and
chronic pain, including post-operative
pain, dental pain, musculo-skeletal pain, acute traumatic pain and
cancer pain.
4.2 Posology and method of administration
Oral use.
_ADULTS_
Dosage may range from 1 to 3 tablets three times daily depending on
the pain severity and the patient's
response. The recommended starting dosage is 1 or 2 tablets three
times daily.
_SPECIAL POPULATIONS_
Children: Since the safety and efficacy of nefopam in children under
12 years has not yet been
established, the administration of Nefopam 30 mg tablets is not
recommended in the pediatric population.
Elderly: Dosage adjustment may be required due to slower metabolism.
It is strongly recommended that
the starting dose does not exceed one tablet three times daily as
older people appear more susceptible to,
in particular, the CNS side effects of Nefopam 30 mg tablets and some
cases of hallucinations and
confusion have been reported in this age group.
Patients with end stage renal disease: Since these patients might
experience increased serum peak
concentrations during treatment with nefopam, the daily dose is
recommended be reduced.
4.3 Contraindications
Nefopam 30 mg tablets are contraindicated in patients with
hypersensitivity to the active substance or to
any of the excipients listed in section 6.1.
It is also contraindicated in patients with a history of convulsive
disorders and should not be given to
patients taking mono-amine-oxidase (MAO) inhibitors.
4.4 Special warnings and p